1Inactivation of protein kinase Cδ on proliferation, apoptosis and related signaling pathways of human os-teosarcoma stem cellsLV Huicheng, JIA Haisheng, MA Min, WANG Mingbo, WU Yimin1057-10622Reversal effect of miR-155 on the resistance of leukemia cells to adriamycin by regulating Ets-1 expressionSHA Min, YE Jun, GUO Ting, ZHANG Lixin, LUAN Zhengyun1063-10673Function study of miR-26b targeting GSK-3βon the anti-stemness of breast cancer cellsMA Deliang, QIN Jing, ZHANG Dianfu1068-10734Anti-proliferation effect of polyenephosphatidylcholine combined with oxaliplatin on gastric cancer cellsGAO Lei, ZHANG Hongjun, JIANG Tao, SONG Hao, ZHAO Yuanyuan, LIU Xiguang1074-10795RAS, CD68 and CD34 expression in breast cancer tissue and their clinical significanceSHI Yue, YUAN Gaofeng, SHI Fengling, FENG Chengting, WU Baoan, LI Wei, TAO Min, LIANG Rongrui1080-10836Expression of SATB1 in Xinjiang Uygur patients with breast cancer and its relationship with clinicopatho-logical featuresJIANG Weihua, SUN Xiaohong, LI Yongtao, ZHANG Mingshuai, WANG Xiaowen, OU Jianghua1084-10877Relationship between the levels of VEGF, MMP-9 and chemotherapy effect in patients with advanced breast cancerLI Li, LIU Delin, WU Yuan, WANG Youqun, SUN Weili1088-10928Expression and clinical significance of nr5A2 and GPC3 in human gastric cancer tissuesBI Ran, GAO Liming, LIU Lijie, ZHANG Shuang, JIN Tian, JIA Hongju, ZHENG Lei, HE Yuqing, FU Zhanzhao1093-10989Expression and clinical significance of BLZF1 in human gastric cancer tissuesFENG Changyi, WU Haiyan, XU Zizhi, LIU Kaiyuan1099-110210A single center, single arm and phase Ⅱ clinical trail：efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced NSCLC patients with secondary drug resistanceZHU Yanzhe, PAN Yueyin, DU Yingying, LIU Hu, MA Tai, SHEN Yuanyuan1103-110911Association of clinical pathological characteristics and prognosis with lymph node metastasis of non-small cell lung cancerLIN Xiao, CHEN Yusheng, LI Hongru, ZENG Dunhuang, WU Yanling1110-111612Recombinant human endostatin combined with cisplatin perfusion chemotherapy for malignant pleural effu-sions:a Meta-analysisYANG Minjie, HE Wei, WANG Feng, WU Mengjiao, FAN Qingxia1117-112313Clinical significance of serum lactate dehydrogenase andβ2-microglobulinin in patients with diffuse large B-cell lymphomaZHAO Shuqing, LI Junmin, CHEN Li, YANG Chenmin1124-112714Comparison of the transperitoneal and retroperitoneal approach in robotic-assisted laparoscopic partial ne-phrectomy in treatment of renal carcinomaTANG Hao, ZHANG Zhengyu, ZHOU Wenquan, WEI Wu, XUE Song, DONG Jie, ZHOU Zhongkui, GE Jingping1128-113115Comparison on efficacy of two kinds of lead brick treatment modalities in the four-field whole pelvic irradi-ation for cervical cancer with uterus excursionLIN Gaojuan, LIU Taowen, XU Lirong, YE Shiqi, FENG Kaiyong, ZHAO Huiling1132-113516CT-guided coil localization and VATS resection under radioscopy for subcentimeter pulmonary nodulesSUN Yijun, XU Jian, YI Jun, LI Demin1136-113917The expression of PD-L1 in tumor and its related mechanism researchLEI Zemin, MO Xiangyang, YU Zongyang1140-114418Significance of hypoxia tumor microenvironment and hypoxia inducible factors to CSCs,EMT and CTCsSUN Wenwen, XU Zhihong, GAO Beili, HU Jiaan1145-1148 